ClinicalTrials.gg
Sign In
CompletedNCT01027507Updated Dec 8, 2009

Postprandial Hemodynamics

An observational study in Heart Disease, sponsored by Skane University Hospital. Completed at 1 site in Sweden. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-12-08.

Sponsored by Skane University Hospital · Observational

Study type
Observational
Model
Case-only
Enrollment
23
Ages
18 Years and older
Sex
All
01

Study summary

To study the postprandial alterations in hemodynamics and blood pressure in relation to gastric emptying rate, postprandial blood glucose, plasma concentrations of insulin, satiety in healthy subjects.

Read the detailed description

Ingestion of a meal increase blood flow to the gastrointestinal organs and affects the heart rate, blood pressure, and cardiac output. It is not known through wich mechanisms the heart function changes affects after a meal.

02

Conditions studied

  • Heart Disease

Browse trials for

03

In context

Heart Diseases

3,673 studies on the registry are indexed under Heart Diseases; 458 are open to participants now.

This study's enrollment of 23 is below the median of 296 across 1,249 observational studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

Skane University Hospital is the lead sponsor of 73 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy subjects without symptoms or a history of gastrointestinal disease, abdominal surgery or diabetes mellitus, were included in this crossover study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy subjects

Exclusion criteria

Exclusion Criteria:

  • history of gastrointestinal disease, abdominal surgery or diabetes mellitus
05

Study design

Observational model
Case-only
Enrollment
23 participants (actual)
06

Study locations

1 site
  • Departments of Medicine, Malmö University Hospital
    Malmö, 205 02, Sweden
07

References and documents

Publications

  • Dencker M, Bjorgell O, Hlebowicz J. Effect of a standardized meal on inflammatory biomarkers. Scand J Clin Lab Invest. 2026;86(2):95-109. doi: 10.1080/00365513.2026.2630318. Epub 2026 Feb 14. PubMed 41689559 ↗
  • Dencker M, Bjorgell O, Hlebowicz J. Effect of food intake on 92 oncological biomarkers by the Proseek Oncology II panel. BMC Res Notes. 2019 Apr 2;12(1):199. doi: 10.1186/s13104-019-4237-9. PubMed 30940215 ↗
  • Hlebowicz J, Lindstedt S, Bjorgell O, Dencker M. The effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure. Cardiovasc Ultrasound. 2011 Dec 29;9:43. doi: 10.1186/1476-7120-9-43. PubMed 22206473 ↗
  • Hlebowicz J, Lindstedt S, Bjorgell O, Dencker M. Relationship between postprandial changes in cardiac left ventricular function, glucose and insulin concentrations, gastric emptying, and satiety in healthy subjects. Nutr J. 2011 Mar 23;10:26. doi: 10.1186/1475-2891-10-26. PubMed 21429209 ↗
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2009 and a completion of Nov 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 7, 2009
First posted
Dec 8, 2009
Start
Jan 2009
CompletionActual
Nov 2009
Last update
Dec 8, 2009
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 8, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01027507
Lead sponsor
Skane University Hospital
First posted
Dec 8, 2009
Start date
Jan 2009
Completion
Nov 2009
Last update
Dec 8, 2009

Study contacts

Joanna Hlebowicz, MD, PhD
principal investigator · Skane University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Heart Diseases →

Other studies from this sponsor

Skane University Hospital

Start the discussion